[Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].

作者：Juan Li, Zhixian Guo, Jianan Chen, C Xue, Lulu Sun, Zhigang Ren, Ang Li, Guangying Cui, Zujiang Yu · 发表于：PubMed · 年份：2019 · DOI：10.3760/cma.j.issn.1007-3418.2019.03.005 · 被引用次数：3 · 研究领域：Epigenetics and DNA Methylation、Cancer-related gene regulation、Ubiquitin and proteasome pathways

An evident high expression of CBX2 is an independent poor prognostic factor in hepatoma. Down-regulation of CBX2 expression can inhibit the progression of liver cancer. Therefore, CBX2 may be a prognostic biomarker and a new target for HCC treatment.